StreetInsider.com News Articles

Form 8-K Lipocine Inc. For: Sep 08

Fri, 11 Sep 2026 06:10:00 -0400

si-local-file:///var/storage/secattach/20260911/27050503.html

Lipocine to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Thu, 10 Sep 2026 08:00:00 -0400

SALT LAKE CITY, Sept. 10, 2026 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a specialty pharmaceutical company focused on the development of novel oral therapeutics, today announced that Company management will present and meet with investors at the H.C. Wainwright 28th Annual Global Investment Conference, to be held in person and virtually September 14-16, 2026.

Lipocine to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Thu, 10 Sep 2026 08:00:00 -0400

Form 8-K Lipocine Inc. For: Sep 10

Thu, 10 Sep 2026 06:14:00 -0400

si-local-file:///var/storage/secattach/20260910/27044716.html

Form 8-K/A Lipocine Inc. For: Aug 03

Fri, 21 Aug 2026 16:30:00 -0400

si-local-file:///var/storage/secattach/20260821/26961790.html

Form 8-K/A Lipocine Inc. For: Aug 03

Fri, 21 Aug 2026 16:30:00 -0400

si-local-file:///var/storage/secattach/20260821/26961790.html

Form SCHEDULE 13G/A Lipocine Inc. Filed by: Squadron Capital Management LLC

Fri, 14 Aug 2026 13:02:00 -0400

si-local-file:///var/storage/secattach/20260814/26928158.html

Form SCHEDULE 13G/A Lipocine Inc. Filed by: Squadron Capital Management LLC

Fri, 14 Aug 2026 13:02:00 -0400

si-local-file:///var/storage/secattach/20260814/26928158.html

Form 4 Lipocine Inc. For: Aug 03 Filed by: Grissinger Michael

Fri, 07 Aug 2026 16:11:00 -0400

si-local-file:///var/storage/secattach/20260807/26891148.html

Form 4 Lipocine Inc. For: Aug 03 Filed by: Grissinger Michael

Fri, 07 Aug 2026 16:11:00 -0400

si-local-file:///var/storage/secattach/20260807/26891148.html

Form 3 Lipocine Inc. For: Aug 03 Filed by: Grissinger Michael

Fri, 07 Aug 2026 16:07:00 -0400

si-local-file:///var/storage/secattach/20260807/26891047.html

Form 3 Lipocine Inc. For: Aug 03 Filed by: Grissinger Michael

Fri, 07 Aug 2026 16:07:00 -0400

si-local-file:///var/storage/secattach/20260807/26891047.html

Lipocine (LPCN) Tops Q2 EPS by 12c

Tue, 04 Aug 2026 16:48:07 -0400

Lipocine (NASDAQ: LPCN) reported Q2 EPS of ($0.32), $0.12 better than the analyst estimate of ($0.44). Revenue for the quarter came in at $190 million versus the consensus estimate of $162.5 thousand.

For earnings history and earnings-related data on Lipocine (LPCN) click here.

Lipocine Announces Financial Results for the Second Quarter Ended June 30, 2026